An overview is presented of the PNSAT, a tool for measuring the value of a navigation program from organizational context to community engagement.

A presentation at AONN+ Annual Conference draws a connection between navigation and improved clinical trial accrual and NGS testing adherence.

An overview of the role of the navigator, its history and evolution, and the development of practice standards are discussed.

Smaller declines seen in early-stage cancer diagnosis during COVID-19 pandemic in adults aged 18 to 44 years, men, those with high comorbidity burden.

Study validates FACIT-Fatigue scale for assessment of cancer-related fatigue in patients with locally advanced/metastatic breast cancer.

Overall, 41.7% of cancer deaths in 2023 were attributed to potentially modifiable risk factors, with behavioral risk factors having the greatest impact.

Patients with 15-day MRD less than 10% blasts fared better than those with 10% or greater, even if they had other high-risk factors.

Updated NCCN SCLC guidelines recommend testing patients with suspected PNS; however, researchers found screening uptake in the US is low.

A review of JADER and FAERS databases identified common adverse effects for 3 antibody-drug conjugates with the same type of payload.

Investigators assessed the independent associations of albuminuria and eGFR with overall and site-specific cancers using data from more than one million patients in the Chronic Kidney Disease ...

Compared to no legalization, medical marijuana legalization with state-run dispensaries appears to increase the risk of adverse hospital events among cancer patients receiving surgery.

Men who improve their adherence to ACS guidelines following diagnosis have a reduction in all-cause and cardiovascular mortality compared to those who maintain a low concordance with guideline ...